Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Breast cancer seeking agents: basic approach

L Maffioli1, E Seregni, S Nerini Molteni

  • 1Division of Nuclear Medicine, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)
|September 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pilot scale validation campaign of gel dosimetry for pre-treatment quality assurance in stereotactic radiotherapy.

Physica medica : PM : an international journal devoted to the applications of physics to medicine and biology : official journal of the Italian Association of Biomedical Physics (AIFB)·2023
Same author

Late toxicities burden in patients with radioiodine-refractory differentiated thyroid cancer treated with lenvatinib.

Endocrine·2021
Same author

Radioembolization of hepatocarcinoma with <sup>90</sup>Y glass microspheres: treatment optimization using the dose-toxicity relationship.

European journal of nuclear medicine and molecular imaging·2020
Same author

Anti-PSMA <sup>124</sup>I-scFvD2B as a new immuno-PET tool for prostate cancer: preclinical proof of principle.

Journal of experimental & clinical cancer research : CR·2019
Same author

An improved automated one-pot synthesis of O-(2-[<sup>18</sup>F]fluoroethyl)-L-tyrosine ([<sup>18</sup>F]FET) based on a purification by cartridges.

Nuclear medicine and biology·2019
Same author

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies.

Journal of endocrinological investigation·2018

Understanding how radiotracers accumulate in tissues is key for nuclear medicine imaging and designing new radiopharmaceuticals. This review examines mechanisms of radiotracer uptake for breast cancer imaging, including 18F-fluorodeoxyglucose (FDG).

Area of Science:

  • Biochemistry
  • Physiology
  • Nuclear Medicine Imaging

Background:

  • Knowledge of tissue localization mechanisms is crucial for interpreting diagnostic nuclear medicine imaging.
  • Cellular mechanisms like altered perfusion and metabolism contribute to high cancer uptake of radiotracers.
  • This enhanced uptake can create a favorable tumor-to-background ratio for imaging.

Purpose of the Study:

  • To review the mechanisms of uptake for relevant radiotracers used in breast cancer imaging.
  • To examine the cellular uptake and release of these agents based on scientific evidence.
  • To report preliminary studies on the cellular uptake and release of novel compounds.

Main Methods:

  • Review of scientific literature on radiotracer uptake mechanisms.

Related Experiment Videos

  • Analysis of cellular uptake and release data for various radiopharmaceuticals.
  • Inclusion of preliminary data from clinical trials.

    • Main Results:

    • Radiotracers, including monoclonal antibodies and cardiovascular tracers, show promise for breast cancer imaging.
    • Established agents like Radiothallium, Sestamibi, and Tetrophosmin, originally for other applications, are used as tumor-seeking agents.
    • 18F-fluorodeoxyglucose (FDG) is a key radiotracer for breast cancer imaging.

    Conclusions:

    • Understanding radiotracer uptake mechanisms is vital for advancing nuclear medicine and radiopharmaceutical design.
    • Various radiotracers, both specifically designed and repurposed, demonstrate potential for breast cancer imaging.
    • Further research into cellular uptake and release mechanisms will refine diagnostic capabilities.